United States (US) Angina Market (2025-2031) | Size & Revenue, Analysis, Growth, Share, Industry, Value, Segmentation, Forecast, Competitive Landscape, Trends, Companies, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Angina Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Angina Market - Industry Life Cycle

3.4 United States (US) Angina Market - Porter's Five Forces

3.5 United States (US) Angina Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Angina Market Revenues & Volume Share, By Types, 2021 & 2031F

3.7 United States (US) Angina Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cardiovascular diseases in the US

4.2.2 Growing aging population leading to higher incidence of angina

4.2.3 Technological advancements in diagnostic tools and treatment options for angina

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of angina medications and therapies

4.3.2 High cost associated with treatment and management of angina

4.3.3 Increasing competition among market players leading to pricing pressures

6.1 United States (US) Angina Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Angina Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Angina Market Revenues & Volume, By Beta Blockers, 2021- 2031F

6.1.4 United States (US) Angina Market Revenues & Volume, By Nitrates and Calcium Channel Blockers, 2021- 2031F

6.1.5 United States (US) Angina Market Revenues & Volume, By Angiotensin-Converting Enzyme Inhibitors, 2021- 2031F

6.1.6 United States (US) Angina Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Angina Market, By Types

6.2.1 Overview and Analysis

6.2.2 United States (US) Angina Market Revenues & Volume, By Stable Angina and Unstable Angina, 2021- 2031F

6.2.3 United States (US) Angina Market Revenues & Volume, By Variant (Prinzmetal) Angina, 2021- 2031F

6.2.4 United States (US) Angina Market Revenues & Volume, By Microvascular Angina, 2021- 2031F

6.3 United States (US) Angina Market, By End User

6.3.1 Overview and Analysis

6.3.2 United States (US) Angina Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Angina Market Revenues & Volume, By Cardiology Centers, 2021- 2031F

6.3.4 United States (US) Angina Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Angina Market Export to Major Countries

7.2 United States (US) Angina Market Imports from Major Countries

8.1 Number of new cases of angina diagnosed annually in the US

8.2 Adoption rate of innovative treatment options for angina

8.3 Average age of patients diagnosed with angina

8.4 Patient satisfaction and outcomes post-treatment

8.5 Research and development investment in angina therapies

9.1 United States (US) Angina Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Angina Market Opportunity Assessment, By Types, 2021 & 2031F

9.3 United States (US) Angina Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 United States (US) Angina Market Revenue Share, By Companies, 2024

10.2 United States (US) Angina Market Competitive Benchmarking, By Operating and Technical Parameters